Is Non-Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?

OBJECTIVE

The objective of this study was to investigate predictive factors for residual disease in acquired cholesteatoma and determine whether the quality of the matrix having a continuous versus disrupted lining-sac versus nonsac contained-impacts the outcomes.

STUDY

DESIGN

Retrospective cohort study.

SETTING

Academic teaching hospital.

METHODS

Pediatric and adult EAONO-JOS-staged acquired cholesteatoma operated with endoscopic and combined approaches by the senior author from January 2015 to November 2023 were included. Presence of residual disease was determined through second-look surgery, MRI with DWI, or by clinical examination following canal wall down mastoidectomy. Initial occurrence of residual disease was examined relative to age, sac versus non-sac contained matrix, ossicular status, and surgical approaches using Cox proportional hazard models. Kaplan-Meier curves were used to visualize time to disease stratified by predictive factors.

RESULTS

Out of 105 ears included, 42% had residual disease. In isolation, non-sac contained cholesteatoma (hazard ratio [HR] 3.89, 95% confidence interval [CI] 1.53-9.89), pediatric patients (HR 1.97, 95% CI 1.01-3.85), incus erosion (HR 2.43, 95% CI 1.17-5.05), and stapes erosion (HR 2.01, 95% CI 1.02-4.00) were significantly more likely to develop residual disease. EAONO/JOS stage and surgical approach were not significantly related. In multivariable modeling, only matrix quality retained significance, with non-sac contained matrix associated with a threefold higher hazard of residual disease (HR 3.05, 95% CI 1.17-7.93).

CONCLUSION

When accounting for several factors inherent to the disease process as well as surgical approach, a non-sac contained cholesteatoma matrix was 3 times more likely to lead to residual disease in acquired cholesteatoma among all ages.